Research and Markets - Gene Editing Markets (CRISPR-based, Zinc Finger Nuclease [ZFN], TALEN, Other) Report 2016 with Profiles of MilliporeSigma, Horizon Discovery Group, OriGene, ThermoFisher Scientific, and ToolGen.

News provided by

Oct 17, 2016, 07:42 ET

DUBLIN, October 17, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Gene Editing Markets (CRISPR-based, Zinc Finger Nuclease [ZFN], TALEN, Other)" report to their offering.

Genome editing is the process of modifying the DNA of a particular organism, by introducing breaks at specific, targeted locations in the genome. At the present time, ZFNs, TALENs and CRISPR-Cas9 are the most used and commercially developed technologies.

The report provides revenues and forecasts by technology, including: global revenues and forecast for the CRISPR-based market by type of product, 2014-2020 (reagents & tools, research services, edited cell lines, edited animal models, total market); global revenues and forecast for the ZFN market by type of product, 2014-2020 (reagents & tools, Research services, Edited cell lines, Edited animal models, Total Market); global revenues and forecast for the TALEN market by type of product, 2014-2020 (reagents & tools, research services, edited cell lines, edited animal models, total market); and global revenues and forecast for other gene editing technologies market by type of product, 2014-2020 (reagents & tools, research services, edited cell lines, edited animal models, total market).

The competition has increased in recent years among the companies active in this market, particularly in the CRISPR/Cas9 segment, as new products have been developed and introduced to market. In 2016, multiple players participate in this market, from large multinational corporations to small, niche life sciences companies. These companies develop and commercialize various products and services for each of the major gene editing technologies.

Companies profiled in the report include include MilliporeSigma, Horizon Discovery Group, OriGene, ThermoFisher Scientific, and ToolGen.

Gene editing technologies have a multitude of commercial applications in numerous fields, such as the development of human therapeutics, new varieties of plants, new breeds of animals, improved animal models for research, and novel sources of chemicals and energy. Gene Editing Markets (CRISPR-based, Zinc Finger Nuclease [ZFN], TALEN, Other) provides detailed descriptions of these applications.

Key Topics Covered:

1: Executive Summary

Overview of Gene Editing
Commercial Applications of Gene Editing Technologies
Selected Commercial Gene Editing Products
Industry Structure
Market Trends
Total Market Revenues and Forecast

2: Introduction and Applications of Gene Editing Technologies

Overview of Gene Editing
Current Major Genome Editing Technologies
Commercial Applications of Gene Editing Technologies
Human Therapeutics
Plant Engineering
Animal Breeding/Research Models

3: Gene Editing Technologies

Zinc Finger Nucleases (ZFNs)
Transcription Activator-Like Effector Nucleases (TALENs)
Selected TALEN Gene Editing Products and Technologies
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)-Cas9
Advantages and Limitations of CRISPR-Cas9 Technology
Selected CRISPR-Cas9 Gene Editing Products
Other Gene Editing Technologies
Meganucleases
The rAAV Technology

4: Industry Structure

Tiers of Competition
Barriers to Entry
Competitive Factors
Notable Mergers and Acquisitions
Regulatory Aspects of Genetic Editing
Market Trends
Increasing Development of Therapeutics Using Gene Editing Technologies to
Augment Market Revenues
Intensified R&D Activity in Non-medical Fields to Accelerate Market Growth
Increasing Investments and Funding in Gene Editing Area to Augment Market
Revenues
Growing Awareness about Gene Editing Technologies among Researchers to Spur
Utilization of Gene Editing Technologies
Limitations of Available Technologies to Constrain Market Growth
Ethical Considerations to Restrain Utilization and Market Growth
Regulatory Constraints to Impede Market Expansion
Patent Disputes to Slow Market Growth

5: Total Market Revenues and Forecast

Market Snapshot
Total Market Forecast
Market Revenues and Forecast by Technology
Zinc Finger Nuclease (ZFN) Technologies
TALEN Technologies
CRISPR-based Technologies
Other Gene Editing Technologies

6: Company Profiles

Agilent Technologies, Inc.
Allele Biotechnology
Applied Biological Materials, Inc.
Applied StemCell Inc.
Caribou Biosciences, Inc.
Cellectis, Inc.
CRISPR Therapeutics AG
Dharmacon
DNA2.0, Inc.
Editas Medicine
GeneCopoeia
GenScript
Horizon Discovery Group, Plc
Integrated DNA Technologies
Intellia Therapeutics
MilliporeSigma
ZFN Products
CRISPR/Cas9 Genome Editing Tools
OriGene Technologies, Inc.
PNA Bio, Inc.
Precision BioSciences
Sangamo Biosciences, Inc.
Santa Cruz Biotechnology, Inc.
System BioSciences
Takara Bio USA (Clontech Laboratories)
ThermoFisher Scientific
TALEN Products
CRISPR Products
GeneArt Engineered Cell Models
ToolGen, Inc.
Transposagen, Inc.
CRISPR-Cas9 Products
XTN TALEN Products
TriLink Biotechnology For more information about this report visit http://www.researchandmarkets.com/research/wnrkpn/gene_editing